ライフサイエンスコーパス: postsurgery

1 ry only, for 24 hr postsurgery, or for 72 hr postsurgery).

2 hout long-term cognitive decline at 3 months postsurgery.

3 tely after surgery as well as on day 2 and 7 postsurgery.

4 s 75% and five patients developed metastases postsurgery.

5 eline; at 1, 3, and 6 weeks; and at 6 months postsurgery.

6 100% recovery of the liver mass after 6-7 d postsurgery.

7 tochondrial complex I were evident on day 14 postsurgery.

8 presented with a caged rattlesnake pre- and postsurgery.

9 fe and emotional functioning during the year postsurgery.

10 postoperative periods and at 8 and 26 weeks postsurgery.

11 W) were measured preoperatively and 8 months postsurgery.

12 cutaneously) and necropsied at 2 or 10 weeks postsurgery.

13 return of lesion-induced deficits by Week 5 postsurgery.

14 d lesions significantly disrupted PPI 1 week postsurgery.

15 the distal surface of tooth #8 at 15 months postsurgery.

16 e first phase of cell death peaked at 1 hour postsurgery.

17 al PGA-TMC could not be observed at 24 weeks postsurgery.

18 prior to surgery; and at 3, 6, and 9 months postsurgery.

19 erative protocol and were evaluated 6 months postsurgery.

20 as the global rating scale score for 2 weeks postsurgery.

21 ver 64 years and were followed for 18 months postsurgery.

22 ted, and all animals regained weight quickly postsurgery.

23 aphs were obtained at baseline and at 1-year postsurgery.

24 mm with CTG (96% root coverage), at 6 months postsurgery.

25 ses, it completely resolved within 12 months postsurgery.

26 was observed at 1-5 min after PHx and 60 min postsurgery.

27 tive protocol and were evaluated at 6 months postsurgery.

28 antly in both groups after 1, 2, and 3 years postsurgery.

29 prior to surgery, and at 6, 9, and 12 months postsurgery.

30 ative pain scores from end of surgery to 6 h postsurgery.

31 across TNM stages I to III and years 1 to 5 postsurgery.

32 t models that capture outcomes up to 90 days postsurgery.

33 improvements in cognitive function were seen postsurgery.

34 ell as what factors influence change in mGFR postsurgery.

35 were significant and sustained over 2 years postsurgery.

36 or to graft-replacement, and at 36 degrees C postsurgery.

37 toperative MME (17.9%) by 2.8 +/- 1.5 months postsurgery.

38 latelets intraoperatively or within 24 hours postsurgery.

39 visit, 12 months postsurgery, and 24 months postsurgery.

40 ves cutaneous scar appearance by 47% 9-month postsurgery.

41 associated adverse event (AE) within 90 days postsurgery.

42 was the incidence of SSI-CRANs within 1 year postsurgery.

43 ntage appeared to extend to at least 8 years postsurgery.

44 ropomyosin-related kinase B), all at 4 weeks postsurgery.

45 e processing in male mice at 6, 24, and 72 h postsurgery.

46 ity of life, and complications up to 3 years postsurgery.

47 plications on HRQOL seem to minimize 5 years postsurgery.

48 in AMPA receptor subunit composition at 72 h postsurgery.

49 +/- 12.3 degrees, respectively, at 3 months postsurgery.

50 , this narrowing remained stable at 3 months postsurgery.

51 y guide the long-term management of patients postsurgery.

52 F paralysis that did not recover by 13 weeks postsurgery.

53 dity, mortality, and quality of life 4 weeks postsurgery.

54 ower total and prescription costs by 3 years postsurgery.

55 associated with long-term cognitive outcome postsurgery.

56 mary outcome was physical fatigue at 1 month postsurgery.

57 lateral leg venography between 7 and 11 days postsurgery.

58 the urine albumin-creatinine ratio on day 7 postsurgery.

59 mptoms and quality of life (QOL) of pre- and postsurgery.

60 ttent intravenous paracetamol up to 48 hours postsurgery.

61 rity and neovascularization on days 7 and 28 postsurgery.

62 rogated, and OA was prevented up to 12 weeks postsurgery.

63 nee joints after ACLT, particularly on day 7 postsurgery.

64 salvage both in the short-term and at 1 year postsurgery.

65 X-II) levels were measured on days 35 and 70 postsurgery.

66 Animals were killed on day 70 postsurgery.

67 f bisphosphonate use on the risk of fracture postsurgery.

68 mug/ml; n = 14 rats) were performed on day 7 postsurgery.

69 histologic analysis after 70 days (10 weeks) postsurgery.

70 ease: two stage 2A with gross residual tumor postsurgery, 11 stage 2B with ipsilateral or midline lym

71 Postsurgery, 13 patients had visible residual disease, a

72 ng 30.1% with acute coronary syndrome, 22.9% postsurgery, 13.3% respiratory failure, and 8.4% ventric

73 mL) was higher than OPN greater than 6 weeks postsurgery (177 ng/mL +/- 29 ng/mL; P = .003).

74 as numerically higher in IE patients 3 years postsurgery (29.6% for BVD vs. 43.9% for IE), Kaplan-Mei

75 markedly improved corneal sensation 6 months postsurgery (3 eyes; mean [SD] central esthesiometry, 55

76 PedEyeQ) at baseline and 1, 6, and 12 months postsurgery.(3,4) Main outcome measures: Median change i

77 impacted postsurgery OPN: OPN < or = 6 weeks postsurgery (303 n/mL +/- 26 ng/mL) was higher than OPN

78 een in sham-operated animals at 1 and 3 days postsurgery (39.5% +/- 2.5 and 44% +/- 1.0, respectively

79 of 8.8+/-2.3 mm to 4.4+/-1.6 mm at 6 months postsurgery (4.4+/-1.5 mm gain), while PD was reduced fr

80 .1 mm presurgery to 3.3+/-1.1 mm at 6 months postsurgery (5.0+/-1.8 mm reduction).

81 Presurgery and postsurgery (6-month) data were compared using Student's

82 Among 552 patients admitted to the ward postsurgery, 68 (12.3%) developed at least one grade I t

83 ada, and had available ERAS and up to 1-year postsurgery administrative data.

84 At 3 months postsurgery, Allegretto provided significantly better ou

85 ed groups showed changes in social dominance postsurgery, although changes in other measures varied b

86 25% increase in fracture risk at 2.5-5 years postsurgery among patients undergoing a THR.

87 and significantly less frequently with year postsurgery among the 995 respondents with assessable re

88 n=56, male), which were imaged up to 28 days postsurgery and 24 hours after systemic thrombolysis (Ac

89 The case rate for CRF was 24% (n = 51) postsurgery and 31% (n = 69) at end of treatment; it bec

90 ationship between functional outcome 3 years postsurgery and 4 predictor domains: pain or complicatio

91 t in 78% of cases, the signature was reduced postsurgery and disappeared entirely in 33%.

92 Calvaria were harvested at 12 weeks postsurgery and evaluated histomorphometrically, by cont

93 otographs were taken between 8 and 12 months postsurgery and evaluated using a visual analog scale by

94 in select regions of the defect site by 3 d postsurgery and expanded during the healing process.

95 sents such impairments that last beyond 30 d postsurgery and is associated with increased risk of com

96 are common, primarily occurring within days postsurgery and often transient.

97 , and REC were remeasured at 6 and 12 months postsurgery and osseous measurements repeated at 12 mont

98 We confirmed the prognostic impact of postsurgery and posttreatment ctDNA in patients with res

99 5) the HFHF diet was continued for 3 months postsurgery and the improvement in glucose tolerance cau

100 The animals were euthanized 4 weeks postsurgery and tissue blocks processed for histometric

101 At two months postsurgery and with a regimen of 200 mg of itraconazole

102 uprofen (800 mg 1 hour presurgery and 400 mg postsurgery) and one with a placebo.

103 ation (yes/no), timely initiation (<=90 days postsurgery), and completion of radiotherapy and chemoth

104 at the first postoperative visit, 12 months postsurgery, and 24 months postsurgery.

105 rption, which was markedly increased 2 weeks postsurgery, and prevented the subsequent increase in bo

106 At 3 months postsurgery, animals were administered a selective PDE4B

107 seointegration in a rodent animal model 4 wk postsurgery as compared with untreated implants.

108 hanges in symptom scores between the pre and postsurgery assessments were measured, and compared betw

109 , a narrow radiolucent gap formed by 1 month postsurgery at the initially tight visual interface betw

110 Twenty-eight days postsurgery, barbel axons had grown out several millimet

111 Some trials suggest early worsening of DR postsurgery because of rapid improvements in hyperglycem

112 Postsurgery behaviors independently associated with weig

113 ke peptide 1 response were all predictors of postsurgery beta-cell function, although weight loss app

114 prioritize symptoms for female patients and postsurgery cases.

115 tive observational study to compare pre- and postsurgery changes in reflux symptoms between cholecyst

116 Postsurgery characteristics independently associated wit

117 mal bleeding disorder, usually posttrauma or postsurgery, characterized by reduced levels of coagulat

118 TNM stage and year postsurgery clearly affect follow-up practice; this anal

119 ptide rose during hypoglycemia but rose less postsurgery compared with presurgery.

120 blems were significantly greater immediately postsurgery compared with retrospective reports before d

121 d 52.0% in SG and RYGBP, respectively, 24 mo postsurgery, compared with initial values.

122 Postsurgery complications occurred in six patients (14%)

123 ral outcome was unrelated to pre-, peri-, or postsurgery complications.

124 ttie-Bresnahan locomotor scores at 1 and 3 d postsurgery confirmed early functional decline in all SC

125 cted baseline (preadmission) and 30/60 days' postsurgery data on activities of daily living, depressi

126 without access to a running wheel (RW) from postsurgery day 0 to 6.

127 n timely biomarker analysis within a 2-month postsurgery delay.

128 Radiographs taken only 5 months postsurgery demonstrated advanced bone loss apical to th

129 5% (calcium and/or active vitamin D 6 months postsurgery) depending on the definition used.

130 rate sensitivity were predictors of eventual postsurgery development of IGT and diabetes.CONCLUSIONDe

131 ication to reduce intraocular pressure (IOP) postsurgery (drop-free).

132 ettings to identify patients at high risk of postsurgery ectasia or those who may benefit most from k

133 iabetes and no venous edema with ulcerations postsurgery (either no history or remission); and presur

134 vs 104 [25] kg; P < .001; mean [SD] pre- vs postsurgery FMD: 9.1% [5.3] vs 10.2% [5.1]; P < .001; me

135 who underwent phacoemulsification and had a postsurgery follow-up of 6 months were included.

136 from January 2016 to February 2021; the last postsurgery follow-up was completed in September 2021.

137 Patients 5 years postsurgery for breast cancer appear to have a very slow

138 raphs were exposed at baseline and 12 months postsurgery for computer assisted densitometric image an

139 Animals were euthanized at 8 and 24 weeks postsurgery for histologic observations.

140 The animals were euthanized at 12 weeks postsurgery for histometric analysis.

141 al attachment (2.59 mm) were obtained 1 year postsurgery for the GTR sites.

142 e association between bisphosphonate use and postsurgery fracture risk.

143 ry phosphorylated alpha-amylase (AMY) in the postsurgery group compared to the presurgery group.

144 Patients experiencing recurrent detachment postsurgery had worse preoperative visual acuity (VA) (1

145 Early-regenerating axons (10 days postsurgery), having no or few myelin layers, were disor

146 significant association of agency hours with postsurgery hemorrhage or hematoma rates, but no breakpo

147 ies leading to spontaneous or posttrauma and postsurgery hemorrhages.

148 , we compared preoperative (68)Ga-RM2 PET to postsurgery histopathology in patients with newly diagno

149 corresponding HRs were weaker after 5 years postsurgery (HRs, 0.64 [95% CI, 0.38-0.97] and 0.99 [95%

150 symptoms were associated with presurgery-to-postsurgery improvements in multiple outcomes at years 1

151 mes were clinically meaningful presurgery to postsurgery improvements in pain and function using scor

152 PP with TE alone before surgery and 6 months postsurgery in adults with tonsillar hypertrophy (sizes

153 SF tracer was significantly enhanced at 30 d postsurgery in both awake and ketamine-xylazine anesthet

154 d GLP-1 concentrations were assessed 30 days postsurgery in GIBP and sham pair-fed (sham.PF) groups.

155 reported cognitive decline observed at 72 h postsurgery in mice might be the consequence of temporal

156 mean time to release was 79.4 +/- 68.8 weeks postsurgery in the phacoemulsification group and 76.0 +/

157 xamined whether short-term changes (</=0.5 y postsurgery) in energy intake and macronutrient composit

158 bsequent increase in bone formation 10 weeks postsurgery, in the untreated tibial plateau of ACLT joi

159 ed a variety of neuropathic symptoms 2 weeks postsurgery, including mechanical and cold allodynia, an

160 /- 10.7, and 29.7 +/- 8.1 degrees at 1 month postsurgery, indicating angle narrowing of 34%-42%, and

161 poly(lactideco-glycolide) for prevention of postsurgery-induced abdominal adhesions.

162 Postsurgery IOL power calculations were performed using

163 n hazard of recurrence between years 5 to 12 postsurgery is 4.3% per year.

164 the latter cohort were compared with matched postsurgery levels.

165 Postsurgery loss to follow-up, relapse, and death were a

166 Seven days postsurgery, LTF was studied in anaesthetized, neuromusc

167 ts was 3.35 mm (SD +/- 0.49) and at 6 months postsurgery, mean recession was 0.47 mm (SD +/0.62).

168 he Student paired t-test to compare pre- and postsurgery measurements.

169 ind utility in therapeutic planning to avoid postsurgery metastatic acceleration.

170 Change in postsurgery mGFR, factors that could influence change in

171 Seven to nine days postsurgery, mice were euthanized, the urinary bladder r

172 espiratory fitness and age in the context of postsurgery mortality and morbidity in older people.

173 Postsurgery mortality and morbidity increase with age.

174 currence of seizures with impaired awareness postsurgery: MRI findings (eg, HR adjusted for other var

175 OPN at recurrence was elevated from postsurgery nadir.

176 Based on postsurgery OGTT, subjects were divided into 3 groups de

177 f tumor-node-metastasis (TNM) stage and year postsurgery on practice patterns.

178 phic surgery claims, patients obtained fewer postsurgery opioid prescriptions over the study period,

179 Postsurgery OPN (256 ng/mL +/- 21 ng/mL) measured at mea

180 to presurgery OPN and use of thoracotomy to postsurgery OPN.

181 Time from surgery significantly impacted postsurgery OPN: OPN < or = 6 weeks postsurgery (303 n/m

182 outcome assessors were blinded until 7 days postsurgery or discharge if earlier.

183 and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk,

184 status (conservatively managed, presurgery, postsurgery, or combined); domain (eg, general cognition

185 (preinjury only, postinjury only, for 24 hr postsurgery, or for 72 hr postsurgery).

186 opeptide content of healthy, presurgery, and postsurgery OSCC patient groups.

187 ative to the nonsurgical cohort after 1 year postsurgery (P < 0.001).

188 /- 2.0 mmHg to 21.1 +/- 2.3 mmHg at 6 months postsurgery (P < 0.001).

189 m 31.5 2.0 mmHg to 21.1 2.3 mmHg at 6 months postsurgery (P < 0.001).

190 failed to vary between 1 month and 3 months postsurgery (P = .481).

191 at baseline to 4.46 +/- 1.70 mm at 6-months postsurgery (p = 0.006).

192 Postsurgery pathologic findings and R0 resection were co

193 , or baseline N stage) predicted the type of postsurgery pathologic response, OS, or DFS.

194 t is not known whether metastatic disease in postsurgery patients inhibits this recovery.

195 ned significantly low in the 13- to 24-month postsurgery period (aORs, 0.77 [95% CI, .68-.86] and 0.7

196 5]) and remained high in the 13- to 24-month postsurgery period (aORs, 1.29 [95% CI, 1.09-1.54] and 1

197 sit or hospitalization in the 0- to 12-month postsurgery period decreased significantly for SSTI (aOR

198 ncreased significantly in the 0- to 12-month postsurgery period for intra-abdominal infection (aOR, 2

199 and return to work (P = .04) over the 6-week postsurgery period, as compared with laparotomy patients

200 ct the association of bariatric surgery with postsurgery pregnancy outcomes.

201 At baseline and at 6 months postsurgery, probing depth and clinical attachment level

202 Postsurgery PRP shows improved cataract surgery results

203 At 28 days postsurgery, pseudophakic cystoid macular edema (PCME) w

204 e identified as predictors of TIA at 1 month postsurgery (R(2) = .907).

205 However, such reconstructive modalities with postsurgery radiotherapy or chemotherapy can hardly supp

206 vaccine platform may be valuable in reducing postsurgery recurrence in a variety of epithelial neopla

207 There were also marked postsurgery reductions in levels of glucagon, cortisol,

208 no history or remission); and presurgery-to-postsurgery reductions in weight and depressive symptoms

209 oncentrations were determined 14 and 28 days postsurgery, reflecting rapid and sustained weight loss

210 in around the initial resected lesion due to postsurgery residual glioma stem cells (GSCs).

211 Tracking and eradicating postsurgery residual GSCs is critical for preventing pos

212 mg/kg) in a within-subject design 2-3 weeks postsurgery revealed a normalization of PPI.

213 vs 10.2% [5.1]; P < .001; mean [SD] pre- vs postsurgery RH: 764% [400] vs 923% [412]; P < .001).

214 At 6-week postsurgery, RV function was assessed via echocardiograp

215 mouse metastatic mammary carcinoma 4T1 in a postsurgery setting, IFN-gamma-deficient mice were found

216 ies given at regular intervals beyond 1 year postsurgery should be tested in future studies, and prov

217 ery, with matched samples from 2 to 5 months postsurgery, showed that in 78% of cases, the signature

218 he present study was to compare at 12 months postsurgery sites treated with open flap debridement (OF

219 t risk factor for having major complications postsurgery [stage 3, odds ratio (OR) = 1.24 (95% CI, 1.

220 nd estimated cumulative incidence at 4 weeks postsurgery, stratified by VTE risk groups, and rated ev

221 At 2 and 8 mo postsurgery, subjects consumed a test drink with 6 mg (5

222 risk factor predicting significantly shorter postsurgery survival (P = 0.03), controlling for the sig

223 hPR (P = .006), R0 resection (P < .001), and postsurgery T and N stages (P = .01 and P < .001, respec

224 EUS T plus N and postsurgery T plus N correlation showed significant down

225 over time, they were still greater at 1 year postsurgery than before diagnosis.

226 m nonoperated controls and from animals 24 h postsurgery that were administered either NK-1RA or sali

227 Similarly, at 24 h postsurgery the mRNA expression of structural proteins (

228 At 6 and 12 wk postsurgery, the hind limb had significantly less bone m

229 At 18 months postsurgery, the intervention group had lower rates of b

230 Postsurgery, the mice were injected with vehicle or FGF2

231 At various times postsurgery, the opioid receptor antagonists naloxone or

232 Seven months postsurgery, the patient experienced no further hemorrha

233 At 9 months postsurgery, the patient is on full enteral nutrition an

234 At 2 years postsurgery, the survival proportion was 80% (95% CI, 68

235 s (two immediate; two late, at several years postsurgery); this occurred in only one bilateral patien

236 ological thromboprophylaxis, or had multiple postsurgery thromboprophylactic agents.

237 At 8 and 14 wk postsurgery, tibiae were significantly shorter than cont

238 ected in the SCAP hydrogel group at the 6-wk postsurgery time point.

239 Histology sections were obtained at 6 months postsurgery to assess percentage of reosseointegration.

240 ed intraperitoneally between 32 and 40 weeks postsurgery to treatment animals.

241 n 14.5% (calcium and active vitamin D 1 year postsurgery) to 28.5% (calcium and/or active vitamin D 6

242 tion with promising potential application in postsurgery tongue reconstruction of patients with tongu

243 In both groups postsurgery, tracer-derived appearance of oral glucose w

244 ient age, tumor size, neurologic status, and postsurgery treatment, and were compared with survival a

245 based symptom management or usual care daily postsurgery, twice weekly postdischarge until 1 month, a

246 s were taken at baseline and 12 to 15 months postsurgery using a Rinn alignment system.

247 m on the second scan when comparing pre- and postsurgery values for each patient.

248 In agreement with our prediction, postsurgery, VLPFC lesioned animals were impaired in per

249 omplete bridging seen in WT controls at 4 wk postsurgery was not observed in Ddr2-deficient mice even

250 Sexual function at 18 months postsurgery was significantly better in the intervention

251 tional metabolic syndrome (mean [SD] pre- vs postsurgery weight: 126 [25] kg vs 104 [25] kg; P < .001

252 dian) global rating scale scores for 2 weeks postsurgery were 76.9 (80) for LAC vs 74.4 (75) for open

253 After adjusting for sex, changes in mGFR postsurgery were associated with higher presurgical age

254 of >=2 lines on the Snellen chart at 1-year postsurgery were classified as pronounced visual improve

255 To control for effects of surgery, women postsurgery were matched to never-obese women.

256 R); and mineralization at 3, 6, and 12 weeks postsurgery were measured using densitometry, histomorph

257 Reductions in GFR postsurgery were only weakly correlated with weight loss

258 apillary fine structure were observed 3 days postsurgery, when limb use was limited.

259 the 5 years before THR, but had higher rates postsurgery, which peaked at years 2.5-5 (adjusted RR 1.

260 (-14%; 95% confidence interval, -21 to -10) postsurgery, with a strong linear relationship existing

261 isk in the cohort of patients presurgery and postsurgery, with the presurgery groups serving as the r